Delivery Order SPE2DB20D3103-SPE2DB23FP3A7
Award Date
8/9/23
Potential Completion Date
8/10/23
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of pharmaceutical products, specifically Xenical 120 mg capsules, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order (DO) with a Firm Fixed Price pricing type, valued at $5,898.94, and has an ultimate completion date of October 31, 2023. The contract was awarded on October 30, 2023,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,719.14 firm fixed-price delivery order is for the supply of Xenical 120 mg capsules, a prescription medication. The contract has an ultimate completion date of December 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Xenical 120 mg capsules. The contract, valued at $2,998.61, has an ultimate completion date of October 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,812.72 firm-fixed-price delivery order covers the supply of XENICAL 120 MG CAPSULE 90S, a pharmaceutical product, with a final completion date of September 21, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award is for the delivery of ORLISTAT 120 MG CAPSULE 90S pharmaceutical products to the Defense Logistics Agency (DLA). The $2,974.61 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, which is a subsidiary of the parent company Cencora, Inc. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,990.44 firm-fixed-price delivery order is for the supply of Orlistat 120 mg capsules. The contract has an ultimate completion date of April 13, 2023 and was awarded on April 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award, valued at $7,106.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4560715315 ORLISTAT 120 MG CAPSULE 90S, a pharmaceutical product. This award is not associated with a set-aside requirement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,009.95 and is for the provision of Orlistat 120 mg capsules. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation (Amerisourcebergen) for the provision of pharmaceutical products and medical supplies. The contract, valued at up to $12,877.79, is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The $3,875.67 firm fixed-price delivery order has a completion date of May 13, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...